🌟 99% Happy customers

📦 Same-day shipping on in-stock items

Catalog Number:
37794
CAS Number:
71939-50-9
Dihydroartemisinin
Purity:
≥ 98% (HPLC)
Documents
$120.88 /1G
Pack Size Availability Price
Request Bulk Quote
Product Information

Dihydroartemisinin is a potent antimalarial compound derived from the sweet wormwood plant, Artemisia annua. This compound is recognized for its rapid action against Plasmodium falciparum, the parasite responsible for the most severe form of malaria. Dihydroartemisinin is often utilized in combination therapies, enhancing treatment efficacy and reducing the risk of resistance. Its unique structure allows for effective penetration of the parasite's membranes, leading to rapid parasite clearance in patients.

In addition to its primary use in treating malaria, dihydroartemisinin is being explored for its potential applications in treating other diseases, including certain cancers and viral infections, due to its ability to induce apoptosis in various cell types. Researchers are particularly interested in its safety profile and versatility, making it a valuable candidate for further pharmaceutical development. With its established efficacy and ongoing research into new applications, dihydroartemisinin stands out as a critical compound in both the pharmaceutical and research sectors.

CAS Number
71939-50-9
Purity
≥ 98% (HPLC)
Molecular Formula
C15H24O5
Molecular Weight
284.35
MDL Number
MFCD00274495
PubChem ID
540327
Melting Point
153 °C (dec.)
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
CAS Number
71939-50-9
Purity
≥ 98% (HPLC)
Molecular Formula
C15H24O5
Molecular Weight
284.35
MDL Number
MFCD00274495
PubChem ID
540327
Melting Point
153 °C (dec.)
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Dihydroartemisinin is widely utilized in research focused on:

  • Antimalarial Treatments: This compound is a key ingredient in artemisinin-based combination therapies (ACTs), which are the standard treatment for malaria. Its effectiveness against resistant strains makes it invaluable in public health.
  • Cancer Research: Studies have shown that dihydroartemisinin exhibits anticancer properties, potentially inhibiting the growth of various cancer cell lines. This opens avenues for developing new cancer therapies.
  • Anti-inflammatory Applications: The compound has demonstrated anti-inflammatory effects, making it a candidate for treating conditions like arthritis and other inflammatory diseases.
  • Drug Delivery Systems: Dihydroartemisinin can be incorporated into nanoparticles for targeted drug delivery, enhancing the efficacy and reducing side effects of treatments.
  • Veterinary Medicine: Its use extends to veterinary applications, particularly in treating parasitic infections in livestock, contributing to better animal health and productivity.

Citations